CHEMICAL GASTRITIS INDUCED BY NAPROXEN IN THE ABSENCE OF HELICOBACTER-PYLORI INFECTION

被引:8
作者
MCCARTHY, CJ
MCDERMOTT, M
HOURIHANE, D
OMORAIN, C
机构
[1] UNIV DUBLIN TRINITY COLL,MEATH HOSP,DEPT GASTROENTEROL,DUBLIN 2,IRELAND
[2] UNIV DUBLIN TRINITY COLL,ADELAIDE HOSP,DEPT GASTROENTEROL,DUBLIN 2,IRELAND
[3] UNIV DUBLIN TRINITY COLL,ADELAIDE HOSP,DEPT PATHOL,DUBLIN 2,IRELAND
[4] UNIV DUBLIN TRINITY COLL,MEATH HOSP,DEPT PATHOL,DUBLIN 2,IRELAND
关键词
HELICOBACTER PYLORI; NAPROXEN; GASTRITIS;
D O I
10.1136/jcp.48.1.61
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Aim - To evaluate the histological changes that occur in the antral mucosa of healthy male subjects before and after one week of naproxen administration, using a chemical gastritis score according to the Helicobacter pylori status. Methods - Nineteen male subjects (mean age 31 years) underwent two endoscopies: one before and the other after one week of naproxen treatment (1 g daily). Antral biopsy specimens were assessed for the presence of H pylori infection and for chemical gastritis, defined as the presence of foveolar hyperplasia, muscle fibres in the lamina propria, oedema, and vasodilatation, in the absence of acute or chronic inflammatory cell infiltrate. Results - Of the 19 subjects, eight had H pylori infection. After one week of naproxen treatment, none of those with H pylori infection developed chemical gastritis, while five of 11 (45%) of those without H pylori infection did. In the absence of H pylori infection there was no evidence of inflammation, either before or after naproxen administration. Conclusions - A different pattern of antral histological change occurs following naproxen administration. This pattern is related to the presence or absence of H pylori infection, suggesting that H pylori status should be determined in histological studies of subjects taking nonsteroidal anti-inflammatory drugs.
引用
收藏
页码:61 / 63
页数:3
相关论文
共 17 条
[1]   REFLUX GASTRITIS - DISTINCT HISTOPATHOLOGICAL ENTITY [J].
DIXON, MF ;
OCONNOR, HJ ;
AXON, ATR ;
KING, RFJG ;
JOHNSTON, D .
JOURNAL OF CLINICAL PATHOLOGY, 1986, 39 (05) :524-530
[2]  
DOOLEY CP, 1988, AM J GASTROENTEROL, V83, P278
[3]   LONG-TERM NONSTEROIDAL ANTIINFLAMMATORY DRUG-USE AND HELICOBACTER-PYLORI INFECTION [J].
GRAHAM, DY ;
LIDSKY, MD ;
COX, AM ;
EVANS, DJ ;
EVANS, DG ;
ALPERT, L ;
KLEIN, PD ;
SESSOMS, SL ;
MICHALETZ, PA ;
SAEED, ZA .
GASTROENTEROLOGY, 1991, 100 (06) :1653-1657
[4]  
JONES STM, 1991, BRIT J RHEUMATOL, V30, P16
[5]  
LANZA FL, 1991, AM J GASTROENTEROL, V86, P735
[6]  
LANZA FL, 1988, NEW ENGL J MED, V303, P136
[7]   LONG-TERM NONSTEROIDAL ANTIINFLAMMATORY DRUG-USE AND GASTRODUODENAL INJURY - THE ROLE OF HELICOBACTER-PYLORI [J].
LOEB, DS ;
TALLEY, NJ ;
AHLQUIST, DA ;
CARPENTER, HA ;
ZINSMEISTER, AR .
GASTROENTEROLOGY, 1992, 102 (06) :1899-1905
[8]  
MERKI H S, 1992, Gastroenterology, V102, pA21
[9]   RELATIONSHIP BETWEEN CAMPYLOBACTER-PYLORI AND GASTRITIS IN HEALTHY HUMANS AFTER ADMINISTRATION OF PLACEBO OR INDOMETHACIN [J].
PETERSON, WL ;
LEE, E ;
FELDMAN, M .
GASTROENTEROLOGY, 1988, 95 (05) :1185-1197
[10]   GASTRITIS IN PATIENTS ON NONSTEROIDAL ANTIINFLAMMATORY DRUGS [J].
QUINN, CM ;
BJARNASON, I ;
PRICE, AB .
HISTOPATHOLOGY, 1993, 23 (04) :341-348